Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition • 09-14 May 2026
|
565-01-001.
Dynamic PET unmasks a reduced Blood-CSF Barrier permeability at the choroid plexus level in multiple sclerosis
Impact: To characterize functional choroid plexus alterations in multiple sclerosis (MS), we developed a novel PET metric that revealed a decreased blood-to-cerebrospinal fluid barrier permeability in choroid plexuses in MS but not Alzheimer's disease, a parameter strongly linked to disease severity.
|
||
|
565-01-002.
High-resolution 3D-T2WI with AIR Recon DL for perivascular space visualization in multiple sclerosis
Impact: High-resolution 3D_ARDL enables consistent detection of small subcortical PVS in MS. This technique may facilitate earlier detection of disease activity and enhance understanding of MS pathophysiology.
|
||
|
565-01-003.
Filter exchange imaging (FEXI) reveals subtle normal-appearing tissue blood-brain barrier dysfunction in MS
Impact: Measurement of blood brain barrier (BBB) water exchange using filter exchange imaging (BBB-FEXI) reveals widespread changes in BBB function in normal-appearing tissue in multiple sclerosis (MS) not seen with gadolinium leakage. These measurements increase our understanding of MS disease mechanisms.
|
||
|
565-01-004.
Association of MRI Indices of the Perivascular Space Network with disease pathology and disability in Multiple Sclerosis
Impact: This study validates glymphatic dysfunction as a key MS mechanism, providing non-invasive MRI biomarkers for disability and neurodegeneration to guide research, personalized care, and targeted therapies.
|
||
|
565-01-005.
Glymphatic Dysfunction in Multiple Sclerosis and its Association with Brain Structural Damage and Cognitive Impairment
Impact: This study provides the evidence that choroid plexus volume enlargement is linked to impaired glymphatic function in RRMS. We identify glymphatic dysfunction as a key mechanism underlying cognitive decline.
|
||
|
565-01-006.
Choroid Plexus Cysts on 7T MRI Differentiate NMOSD from MS
Impact: In young patients, 7T MRI revealed more frequent and
distinct choroid plexus cysts in AQP4+ NMOSD than in RRMS. CPCs were
quantifiable and sometimes present without brain lesions, suggesting a
practical imaging marker to aid differential diagnosis.
|
||
|
565-01-007.
Elevated Choroid Plexus Blood Flow in NMOSD Linked to Cognitive and Emotional Deficits
Impact: Identifies elevated choroid plexus blood flow (ChP-CBF) in NMOSD as a novel MRI biomarker for neuroinflammation-related cognitive-emotional impairments, aiding diagnosis and guiding therapies like anti-complement agents.
|
||
|
565-01-008.
Choroid plexus alterations link metabolic syndrome severity to cognitive domains: neuroimaging evidence from two cohort
Impact: CP enlargement may indicate central metabolic and inflammatory alterations driven by MetS, linking peripheral metabolic dysfunction to cognitive decline, and serving as a potential neuroimaging biomarker of metabolic brain injury.
|
||
|
565-01-009.
Choroid Plexus Changes and Cognitive alterations in Migraine Patients
Impact: This study may elucidate the pivotal role of the choroid plexus in migraine-related cognitive impairment, providing novel imaging biomarkers and theoretical foundations for early identification and intervention of migraine.
|
||
|
565-01-010.
The Choroid Plexus in Brain Waste Clearance: Key Predictors of Volume and Impact on Aβ Deposition Under Anti-Amyloid Therapy
Impact: We identified age, male
sex, and APOE4 status as key predictors of increased choroid plexus volume. Larger
choroid plexus volume correlated with slower Aβ deposition rates, highlighting its important role in brain waste
clearance.
|
||
|
565-01-011.
Dysfunction of the Brain's Microenvironment in Cognitive Impairment of SLE: A Free Water and DTI-ALPS Study
Impact: Free water imaging and the DTI-ALPS index serve as sensitive biomarkers for detecting brain microenvironment alterations in SLE patients with cognitive impairment, enabling early risk identification and guiding targeted interventions to improve patient outcomes.
|
||
|
565-01-012.
Serostatus-Independent Free-Water Fraction in Cervical Spinal WM in NMOSD: Equivalence Analysis with diffusion Standard Model
Impact: FWF
is serostatus-equivalent (±0.02) and exhibits a stable segmental gradient,
enabling serostatus-agnostic pooling, simpler acquisition, and level-normalized
monitoring that strengthen multicenter harmonization and longitudinal care in
NMOSD.
|
||
|
565-01-013.
Decoupling of gBOLD Signals from CSF Flow Reveals Glymphatic Dysfunction in Idiopathic Normal Pressure Hydrocephalus
Impact: This study identifies gBOLD-CSF coupling as a neurophysiological biomarker of impaired glymphatic clearance in iNPH and demonstrates its predictive value for cognitive improvement following shunt surgery, providing a mechanistically informed target for treatment selection and monitoring.
|
© 2026 International Society for Magnetic Resonance in Medicine